The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment-Reference-Cited by-同舟云学术

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment

Published:2014-05 Issue: Volume:50 Page:67-76
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Cambridge G.,Perry H.C.,Nogueira L.,Serre G.,Parsons H.M.,De La Torre I.,Dickson M.C.,Leandro M.J.,Edwards J.C.W.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. B cell depletion therapy in rheumatic disease;Edwards;Best Pract Res Clin Rheumatol,2006

2. Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system;Boumans;Arthr Rheum,2011

3. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis;Leandro;Arthr Rheum,2006

4. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment;Roll;Arthr Rheum,2008

5. Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs;Popa;Rheumatology (Oxford),2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additional use of α-IgM antibodies potentiates CpG ODN2006-induced B cell activation by targeting mainly naïve and marginal zone-like B cells;Cellular Immunology;2024-09

2. Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell–targeted therapy;JCI Insight;2023-03-22

3. Multicentric Reticulohistiocytosis;Rare Diseases of the Immune System;2022

4. B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management;International Journal of Molecular Sciences;2021-12-17

5. Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures;Frontiers in Immunology;2021-11-03